Minoxidine   2 – 5   (SOLUTION)

Treatment of Alopecia

Each 100ml Solution contains 2 or 5g minoxidil.

Minoxidine is a topical solution, which is effective in the treatment of alopecia (hair loss) and alopecia areata. Minoxidine promotes hair growth by direct dilator effect on the peripheral vasa, and is also promoting the epithelium of hair bursa.
Therapy experience gives acceptable percentage of hair re-growth in the treatment of alopecia, and a high percentage of unthick hair re-growth. Good results are achieved in about 50% of patients, when Minoxidine treats the alopecia areata. The response was better when the patients use Minoxidine directly after hair loss. It may be required long period before hair re-growth can be observed (twice daily for over 4 months). If patient responds to treatment, he will need to continue using Minoxidine to maintain hair growth.

Minoxidine is for external use only.
Remove the metal cap of bottle and put the sprayer tightly. Then remove the cover and press sprayer twice to apply a complete dose of 1ml.
One ml dose of Minoxidine should be applied to total affected area of the scalp twice daily. At first Minoxidine must be applied in the center of bald area. The total dosage should not exceed 2ml. Hair and scalp should be dry before application of Minoxidine. Hair drier should not be used because it reduces the effectiveness of Minoxidine. If fingertips are used to facilitate drug application, hands should be washed afterwards.
Minoxidine is used by the same way in the treatment of alopecia areata till hair re-growth occurred, then it might be reduced gradually.

It should not be used in patients with hypertensive.

It may cause itching and other skin irritations to the treated area of the scalp, and rarely skin sensitivity.

If Minoxidine gets into the eye, mucous membranes or sensitive skin areas, wash it with large amount of water.

The product should not be used in pregnancy or lactation, unless the physician consulted.

Carton pack contains glass bottle of 60 ml with sprayer, and leaflet.




© 2010 Domina Pharmaceuticals